viernes, 27 de marzo de 2026

Adding Chemo to Osimertinib Doubles Progression-Free Survival in Advanced NSCLC Kerri Wachter March 27, 2026

https://www.medscape.com/viewarticle/adding-chemo-osimertinib-doubles-progression-free-survival-2026a10009fy European Lung Cancer Congress (ELCC) 2026 https://www.medscape.com/c25/p14/european-lung-cancer-congress-elcc-2026-2026a10006h2

No hay comentarios:

Publicar un comentario